Citadel Advisors - MERRIMACK PHARMACEUTICALS IN ownership

MERRIMACK PHARMACEUTICALS IN's ticker is MACK and the CUSIP is 590328209. A total of 43 filers reported holding MERRIMACK PHARMACEUTICALS IN in Q1 2022. The put-call ratio across all filers is 5.04 and the average weighting 0.3%.

Quarter-by-quarter ownership
Citadel Advisors ownership history of MERRIMACK PHARMACEUTICALS IN
ValueSharesWeighting
Q3 2023$1,051,724
-25.6%
85,298
-25.8%
0.00%
Q2 2023$1,414,464
-67.4%
114,997
-67.4%
0.00%
-100.0%
Q1 2023$4,341,946
+7.1%
353,291
-0.2%
0.00%0.0%
Q4 2022$4,055,694
+3068.5%
353,900
+937.3%
0.00%
Q3 2022$128,000
-23.8%
34,118
+21.4%
0.00%
Q2 2022$168,000
+136.6%
28,111
+148.8%
0.00%
Q1 2022$71,000
+39.2%
11,300
+6.4%
0.00%
Q3 2021$51,000
-73.8%
10,622
-65.3%
0.00%
Q2 2021$195,000
-73.2%
30,652
-73.5%
0.00%
Q1 2021$727,000
+48.7%
115,844
+63.3%
0.00%
Q4 2020$489,000
+579.2%
70,943
+292.0%
0.00%
Q3 2020$72,000
+84.6%
18,100
+53.4%
0.00%
Q2 2020$39,000
+39.3%
11,800
-9.9%
0.00%
Q1 2020$28,000
-9.7%
13,100
+30.5%
0.00%
Q4 2019$31,000
-50.0%
10,042
-26.3%
0.00%
Q3 2019$62,000
-24.4%
13,629
+1.3%
0.00%
Q2 2019$82,000
+26.2%
13,459
-20.7%
0.00%
Q4 2018$65,000
-66.5%
16,972
-53.2%
0.00%
Q3 2018$194,000
-47.0%
36,298
-51.2%
0.00%
Q2 2018$366,000
+205.0%
74,445
+533.8%
0.00%
Q4 2017$120,000
-34.4%
11,746
-6.4%
0.00%
Q3 2017$183,00012,5530.00%
Other shareholders
MERRIMACK PHARMACEUTICALS IN shareholders Q1 2022
NameSharesValueWeighting ↓
Western Standard LLC 1,894,013$23,353,18021.09%
Newtyn Management, LLC 1,873,694$23,102,6475.70%
Sio Capital Management, LLC 288,466$3,556,7861.10%
Madison Avenue Partners, LP 553,085$6,819,5380.97%
WITTENBERG INVESTMENT MANAGEMENT, INC. 209,739$2,5860.95%
Indaba Capital Management, L.P. 136,802$1,686,7690.50%
Sepio Capital, LP 306,680$3,781,3640.33%
Yakira Capital Management, Inc. 54,118$667,2750.18%
Centiva Capital, LP 187,803$2,315,6110.05%
FIFTH LANE CAPITAL, LP 10,929$134,4270.05%
View complete list of MERRIMACK PHARMACEUTICALS IN shareholders